HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma.

Abstract
The chemotherapy of aggressive glioma is usually accompanied by a poor prognosis because of the formation of vasculogenic mimicry (VM) and brain cancer stem cells (BCSCs). VM provided a transporting pathway for nutrients and blood to the extravascular regions of the tumor, and BCSCs were always related to drug resistance and the relapse of glioma. Thus, it is important to evaluate the inhibition effect of antiglioma drug delivery systems on both VM and BCSCs. In this study, paclitaxel-loaded liposomes modified with a multifunctional tandem peptide R8-c(RGD) (R8-c(RGD)-Lip) were used for the treatment of glioma. An in vitro cellular uptake study proved the strongest targeting ability to be that of R8-c(RGD)-Lip to glioma stem cells. Drug loaded R8-c(RGD)-Lip exhibited an efficient antiproliferation effect on BCSCs and could induce the destruction of VM channels in vitro. The following pharmacodynamics study demonstrated that R8-c(RGD)-modified drug-loaded liposomes achieved both anti-VM and anti-BCSC effects in vivo. Finally, no significant cytotoxicity of the blood system or major organs of the drug-loaded liposomes was observed under treatment dosage in the safety evaluation. In conclusion, all of the results proved that R8-c(RGD)-Lip was a safe and efficient antiglioma drug delivery system.
AuthorsYayuan Liu, Ling Mei, Qianwen Yu, Chaoqun Xu, Yue Qiu, Yuting Yang, Kairong Shi, Qianyu Zhang, Huile Gao, Zhirong Zhang, Qin He
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 7 Issue 30 Pg. 16792-801 (Aug 05 2015) ISSN: 1944-8252 [Electronic] United States
PMID26173814 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • Antineoplastic Agents, Phytogenic
  • Liposomes
  • Oligopeptides
  • arginyl-glycyl-aspartic acid
  • Paclitaxel
Topics
  • Angiogenesis Inhibitors (administration & dosage)
  • Animals
  • Antineoplastic Agents, Phytogenic (administration & dosage, chemistry)
  • Apoptosis (drug effects)
  • Brain Neoplasms (drug therapy, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Glioma
  • Liposomes (chemistry)
  • Mice, Inbred BALB C
  • Neoplastic Stem Cells (drug effects, metabolism, pathology)
  • Neovascularization, Pathologic (drug therapy, metabolism, pathology)
  • Oligopeptides (chemistry, pharmacokinetics)
  • Paclitaxel (administration & dosage, chemistry)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: